surmount-1 tirzepatide trial obesity without diabetes Effect of in trial. (BMI: body mass index; CI: For the first time, tirzepatide

Description

Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens

Research indicates that this effect is beneficial in patients with type 2 diabetes (T2D): Mounjaro tirzepatide is approved as a weight loss medication for overweight adults with at least one associated health problem

Tirzepatide, the newest medication for type 2 diabetes: A review of the literature and implications for clinical practice

(Tirzepatide is the active ingredient in Eli Lilly's obesity drug Zepbound.) She'd been taking the drugs already, from a local provider, and called them "life-changing," but made the switch to Zappy hoping to save money